Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.
This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can provide a...
Trump’s (DJT) up 48% Today
LIVE QUOTE
Our only thought is it would be a great idea, to give some of the stock to E Jean Carroll for her lawsuit...
Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...
Taking advantage of post reverse-split investor pessimism, is a VALID investing technique.
Altamira is developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to...
IMAC Holdings (BACK) Explodes 94% Higher Post Reverse Split, With 42 Million Shares Trading...
Simply Incredible! 2024 Will be the Year of Post Reverse Split Revenge!
Taking advantage of post reverse-split investor pessimism, is a VALID investing technique.
IMAC owns and...
China Remains at Risk to Future MonkeyPox Outbreaks.
GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.
The World Health Organization just updated global...
GeoVax Live Webcast
Tonight, Monday at 5:30 PM. And You Don't Fly to Newport Beach and Deal With all the Drinking, Investment Bankers, and Hedge Fund Managers,...
Amylyx (AMLX) Go Kaboom!
The Above Chart Looks Nice..Goldman Sachs (see below) had $46 Price Target.
Market Capitalization at 9:20 $1.29 billion - with a 'B.'
Market Capitalization at 9:31...
Adding Terran Orbital (LLAP) $1.15 to Watch List. Risk Arbitrage Idea.
Lockheed Martin (LMT) Offers $1.00 Per Share to Acquire Terran Orbital.
LIVE QUOTE
Shares of Terran popped in its $1.5 billion trading debut in March of...
Killer, 44-Page Report on GeoVax (GOVX).
And a Nine-Page Summary Report..Great Weekend Reading.
This is one killer report. In fact if we might be so bold, we might even call it...
U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.
New report nearly doubles the GeoVax addressable market of Immunocompromised Patients (i.e. potential customers) from 15 Million, to 23 Million patients! Not updated were...